COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report

Psychosomatics. 2020 Sep-Oct;61(5):544-550. doi: 10.1016/j.psym.2020.05.007. Epub 2020 May 19.

Authors

Yelizaveta Sher¹, Beatrice Rabkin², José R Maldonado³, Paul Mohabir⁴

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA. Electronic address: ysher@stanford.edu.
² Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA.
³ Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA; Departments of Internal Medicine, Surgery, Emergency Medicine & Law, by courtesy, Stanford University Medical Center, Stanford, CA.
⁴ Department of Medicine - Pulmonary, Allergy & Critical Care Medicine, Stanford University Medical Center, Stanford, CA.

No abstract available

Publication types

Case Reports

MeSH terms

Adrenergic alpha-2 Receptor Agonists / therapeutic use*
Aged
Analgesics, Opioid / adverse effects
Antipsychotic Agents / therapeutic use*
Azepines / therapeutic use
Betacoronavirus
COVID-19
Central Nervous System Depressants / therapeutic use
Chlordiazepoxide / adverse effects
Coronavirus Infections / complications
Coronavirus Infections / physiopathology
Coronavirus Infections / psychology
Coronavirus Infections / therapy*
Delirium / drug therapy*
Delirium / etiology
Delirium / physiopathology
Delirium / psychology
Dexmedetomidine / adverse effects
Female
Guanfacine / therapeutic use
Haloperidol / therapeutic use
Humans
Hydromorphone / adverse effects
Hypnotics and Sedatives / adverse effects*
Intensive Care Units
Ketamine / adverse effects
Melatonin / therapeutic use
Midazolam / adverse effects
Oxycodone / adverse effects
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / physiopathology
Pneumonia, Viral / psychology
Pneumonia, Viral / therapy*
Propofol / adverse effects
Psychomotor Agitation / drug therapy*
Psychomotor Agitation / etiology
Psychomotor Agitation / physiopathology
Psychomotor Agitation / psychology
Respiration, Artificial
SARS-CoV-2
Sleep Aids, Pharmaceutical / therapeutic use*
Sleep Disorders, Circadian Rhythm / drug therapy
Sleep Disorders, Circadian Rhythm / etiology
Sleep Disorders, Circadian Rhythm / physiopathology
Tracheostomy
Triazoles / therapeutic use
Valproic Acid / therapeutic use

Substances

Adrenergic alpha-2 Receptor Agonists
Analgesics, Opioid
Antipsychotic Agents
Azepines
Central Nervous System Depressants
Hypnotics and Sedatives
Sleep Aids, Pharmaceutical
Triazoles
suvorexant
Guanfacine
Valproic Acid
Dexmedetomidine
Ketamine
Chlordiazepoxide
Oxycodone
Haloperidol
Melatonin
Hydromorphone
Midazolam
Propofol